Complete response in hepatocellular carcinoma with lymph node metastasis by combination therapy of atezolizumab and bevacizumab: a case report

Sorafenib is the oldest first line systemic treatment in patients with advanced hepatocellular carcinoma (HCC) and has been used exclusively for nearly 10 years. The superiority of administering a combination of atezolizumab plus bevacizumab (AteBeva) compared to sorafenib as first line systemic tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Sang Youn, Lee, Sun Mi, Lim, Jeong Woo, Jeon, Gi Jung, Lee, Hye Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Liver Cancer Association 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035691/
https://www.ncbi.nlm.nih.gov/pubmed/37383089
http://dx.doi.org/10.17998/jlc.2021.09.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035691/
https://www.ncbi.nlm.nih.gov/pubmed/37383089
http://dx.doi.org/10.17998/jlc.2021.09.10

Ejemplares similares